Thymic Carcinoma
📧 Sign up to get email alerts when something new happens for Thymic Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-27Clinical Trial Update: Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma [Phase 3]
A Phase 3 trial evaluating adjuvant treatment for incomplete resection thymoma or thymic carcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) [Phase 3]
Phase 3 trial update evaluating postoperative adjuvant chemotherapy for thymic cancer (FUSCC-Thymic 3) is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy [Phase 2]
This update describes a Phase 2 pilot study assessing the safety and clinical activity of Avelumab in patients with thymoma or thymic carcin…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma [Phase 2]
This report provides an update on a Phase 2 clinical trial of bintrafusp alfa (M7824) in patients with thymic epithelial tumors, thymoma, an…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: PT-112 in Subjects With Thymoma and Thymic Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating PT-112 in patients with thymoma and thymic carcinoma is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection [NA]
Clinical trial update on adjuvant hypofractionation radiotherapy after complete resection of thymic epithelial tumors, with the trial curren…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer [Phase 2]
A Phase 2 clinical trial update examining pembrolizumab in combination with sunitinib malate for refractory metastatic or unresectable thymi…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma [Phase 2]
This Clinical Trial Update describes a Phase 2 neoadjuvant trial of adebrelimab plus chemoradiotherapy for locally advanced thymic carcinoma…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: 6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is evaluating whether six cycles of neoadjuvant chemotherapy provide different outcomes than three cycles f…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: HEARTS Trial for Thoracic Cancers [Phase 2]
HEARTS is a Phase 2 clinical trial targeting thoracic cancers, including non-small cell lung cancer, esophageal cancer, esophagogastric canc…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents [Phase 2]
A Phase 2 trial evaluating the combination of pembrolizumab and lenvatinib in pre-treated thymic carcinoma and thymoma Type B3 has completed…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis
A clinical trial from Shanghai General Hospital evaluates electrocautery resection with hyperthermic intrathoracic chemotherapy (HITHOC) for…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer [Phase 1]
A phase 1 trial evaluating pembrolizumab for unresectable thymoma or thymic carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors [Phase 2]
Phase II trial investigating sacituzumab govitecan in advanced thymic epithelial tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating Sacituzumab Tirumotecan in locally advanced or metastatic thymic carcinoma; the study is not yet recruit…
-
CLINICAL_TRIALS other · 2026-01-07Clinical Trial Update: Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma [Phase 2]
Phase 2 clinical trial evaluating chemotherapy plus cetuximab followed by surgical resection for locally advanced or recurrent thymoma or th…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers [Phase 1]
Phase 1 study assessing safety and early efficacy of KFA115 alone and in combination with pembrolizumab in select advanced cancers; the tria…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Molecular Analysis of Thoracic Malignancies
This clinical trial update describes ongoing molecular analyses of thoracic malignancies, including thymic tumors and thoracic carcinomas, w…
-
CLINICAL_TRIALS other · 2025-12-01Clinical Trial Update: Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma [Phase 2]
A Phase 2 clinical trial is evaluating tislelizumab in combination with anlotinib as second-line therapy for thymoma and thymic carcinoma, a…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating carboplatin and paclitaxel with or without ramucirumab in thymic carcinoma has completed; results have been posted.
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Ivonescimab for the Treatment of Thymic Cancer [Phase 2]
A Phase 2 clinical trial evaluating Ivonescimab for thymic carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial of a CD70-targeted CAR-T therapy for CD70-positive advanced solid tumors is currently recruiting, enrolling patient…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Survival Nomogram for Patients With Thymic Carcinoma [NA]
This clinical trial update reports on a survival nomogram study for patients with thymic carcinoma. The trial has completed.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET) [NA]
A clinical trial led by Institut Curie to characterize the immune infiltrate and molecular features of thymic epithelial tumors (thymomas an…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest [Phase 2]
A Phase 2 clinical trial evaluating intensity-modulated pleural radiation therapy (IMPRINT) for thymic malignancies with pleural metastases;…